This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

A paper proposing NIH reforms is circulating in academic circles and within the agency as scientists search for hints of its ...

Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of ...

If we cut or limit funding for curiosity-driven research, we risk shutting down the pipeline of future innovation,” writes ...

FDA and CDC cuts will only exacerbate problems with tobacco regulation and enforcement, say public health experts ...

Health Secretary Robert F. Kennedy Jr. took office promising ‘radical transparency.’ His plan to reshape the agency is indeed ...

The Trump administration and health secretary Robert F. Kennedy Jr. are ushering in an extraordinary reshaping of health and ...

Advocates of addiction treatment say DOGE’s efficiency goals should include easing regulations that lead patients to dub ...

ASPE and AHRQ are losing key research staff as part of the HHS cuts Tuesday. Current and former employees worry vital ...

With $100 million in federal funds suddenly revoked, New York City’s acting health commissioner says defense against ...

In recording, Makary said little about specific plans for his agency or about the layoffs that have roiled his workforce.

The suit filed Wednesday aims to restore funding and end grant cancellations, arguing they violate NIH’s science-based review ...